Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Griguolo

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
ESMO Open|December 20, 2024
Development of two machine learning models to predict conversion from primary HER2-0 breast cancer to HER2-low metastases: a proof-of-concept studyF Miglietta, A Collesei, C Vernieri, et al.
NPJ Breast Cancer|February 20, 2025
Temporal evolution of breast cancer brain metastases treatments and outcomesMichele Bottosso, Gaia Griguolo, Severine Guiu, et al.
Breast (Edinburgh, Scotland)|February 7, 2020
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological modelLuisa Carbognin, Michele Simbolo, Anna Caliò, et al.
British Journal of Cancer|December 2, 2022
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2025
Prognosis and biological characteristics of ER-low metastatic breast cancer: results from a multicenter cohort and the TONIC trialFederica Miglietta, Manon De Graaf, Claudio Vernieri, et al.
British Journal of Cancer|November 17, 2022
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohortLuca Visani, Ivica Ratosa, Rupert Bartsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2020
<i>PIK3CA</i> Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2<sup>+</sup> Breast Cancer: Association with Prognosis and Integration with PAM50 SubtypeValentina Guarneri, Maria Vittoria Dieci, Giancarlo Bisagni, et al.
Breast (Edinburgh, Scotland)|June 20, 2017
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validationLuisa Carbognin, Isabella Sperduti, Alessandra Fabi, et al.
Journal of the National Cancer Institute|July 31, 2024
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancerDavide Massa, Claudio Vernieri, Lorenzo Nicolè, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
ESMO Open|December 20, 2024
Development of two machine learning models to predict conversion from primary HER2-0 breast cancer to HER2-low metastases: a proof-of-concept studyF Miglietta, A Collesei, C Vernieri, et al.
NPJ Breast Cancer|February 20, 2025
Temporal evolution of breast cancer brain metastases treatments and outcomesMichele Bottosso, Gaia Griguolo, Severine Guiu, et al.
Breast (Edinburgh, Scotland)|February 7, 2020
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological modelLuisa Carbognin, Michele Simbolo, Anna Caliò, et al.
British Journal of Cancer|December 2, 2022
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2025
Prognosis and biological characteristics of ER-low metastatic breast cancer: results from a multicenter cohort and the TONIC trialFederica Miglietta, Manon De Graaf, Claudio Vernieri, et al.
British Journal of Cancer|November 17, 2022
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohortLuca Visani, Ivica Ratosa, Rupert Bartsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2020
<i>PIK3CA</i> Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2<sup>+</sup> Breast Cancer: Association with Prognosis and Integration with PAM50 SubtypeValentina Guarneri, Maria Vittoria Dieci, Giancarlo Bisagni, et al.
Breast (Edinburgh, Scotland)|June 20, 2017
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validationLuisa Carbognin, Isabella Sperduti, Alessandra Fabi, et al.
Journal of the National Cancer Institute|July 31, 2024
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancerDavide Massa, Claudio Vernieri, Lorenzo Nicolè, et al.
Pageof 14